Lyell Immunopharma, Inc. (LYEL)
NASDAQ · Healthcare
Lyell Immunopharma, Inc. Cash Flow 2019–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Operating Cash Flow | -150.0M | -162.4M | -163.7M | -169.6M | -126.2M | -160.9M | 39.5M |
| Depreciation & Amort. | 11.5M | 19.6M | 20.3M | 18.0M | 13.6M | 4.3M | 1.3M |
| Investing Activities | |||||||
| Capital Expenditure | 780,000 | 464,000 | 2.7M | 24.3M | 65.5M | 51.5M | 16.0M |
| Free Cash Flow | -150.8M | -162.9M | -166.4M | -193.8M | -191.8M | -212.4M | 23.4M |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | 0 | 0 | 11.8M | 185,000 |
Lyell Immunopharma, Inc. Cash Flow — FAQ
Lyell Immunopharma, Inc. (LYEL) cash flow over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LYEL's cash flow history?
The chart and table above show Lyell Immunopharma, Inc.'s cash flow by year and by quarter, including the growth rate.